S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance (2015/1/12)|
|Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease (2014/12/11)|
|Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study (2015/1/8)|
|Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015 (2015/2/10)|
|Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015 (2015/2/10)|
|Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference (2014/12/22)|
|Amicus Therapeutics to Present at Leerink Global Healthcare Conference (2015/2/4)|
|Amicus Therapeutics to Present at Oppenheimer Healthcare Conference (2014/12/4)|
|Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium (2015/1/26)|
|Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI) (2014/12/22)|
Click above to view more mutual fund data and stats for fold - Amicus Therapeutics Inc.